Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
about
Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes.Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.Molecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure.Gene expression signatures differ with extent of atherosclerosis in monkey iliac artery.Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapyHigher Levels of Lipoprotein Associated Phospholipase A2 is associated with Increased Prevalence of Cognitive Impairment: the APAC StudyRifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicityFenofibrate: treatment of hyperlipidemia and beyond.Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance.Chemical modulation of glycerolipid signaling and metabolic pathways.Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat/Cholesterol-Diet Fed Mice.The Association between Periodontal Status, Serum Lipid Levels, Lipoprotein Associated Phosholipase A2 (Lp-PLA2) in Chronic Periodontitis Subjects and Healthy Controls.The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study.Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome.Association of Lp-PLA2 G994T gene polymorphism with risk of ischemic stroke in Chinese population.Proteomic analysis of buccal gland secretion from fasting and feeding lampreys (Lampetra morii).
P2860
Q33536636-2E5DEA02-2E2A-4340-9A86-0812526333CBQ33602983-5710483F-FACA-4457-8B13-38B6320BAD2BQ33664201-9184A1DE-9E43-424A-90C3-3D79AD66597DQ35242266-9EC2DC49-1ACC-470C-A24D-CB7BF1C42A71Q35267751-9F3BFCFB-A053-4B93-966B-BADAA892CFFCQ37243907-743ADF76-A50B-484E-9D26-555DDAEBEC01Q37266276-31A83CF0-DC90-4393-87EA-EFA02A53E58DQ37329141-70043409-C0DC-4994-8DAF-91B0B5DDCCA1Q37617482-B10F0563-BCAE-41B3-87CF-2253D5BC9F3EQ38179801-3EA81312-D08F-4A7C-9145-30A4A4B87A97Q40257529-4D1C8B74-06CA-4EA2-B77A-28AB7CAB7235Q47133896-4C753AFC-E6B2-48AD-A623-D9A0F092F4C7Q47139777-1A51B7BA-A54B-41BC-A6FB-2ED27746A9E2Q47140169-269E10CC-103C-4D69-A8AB-907947978D1EQ48270915-5A78C881-9027-4E8A-B9A3-52633354C237Q54936146-3EB3A976-A025-4393-B7B4-67D6B6E3BB49
P2860
Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lipoprotein-associated phospho ...... potential therapeutic target.
@ast
Lipoprotein-associated phospho ...... potential therapeutic target.
@en
Lipoprotein-associated phospho ...... potential therapeutic target.
@nl
type
label
Lipoprotein-associated phospho ...... potential therapeutic target.
@ast
Lipoprotein-associated phospho ...... potential therapeutic target.
@en
Lipoprotein-associated phospho ...... potential therapeutic target.
@nl
prefLabel
Lipoprotein-associated phospho ...... potential therapeutic target.
@ast
Lipoprotein-associated phospho ...... potential therapeutic target.
@en
Lipoprotein-associated phospho ...... potential therapeutic target.
@nl
P2093
P2860
P921
P356
P1476
Lipoprotein-associated phospho ...... potential therapeutic target.
@en
P2093
Jeffrey L Anderson
John F Carlquist
Joseph B Muhlestein
P2860
P304
P356
10.1586/14737159.7.5.511
P577
2007-09-01T00:00:00Z